P Liebisch, S Eppinger, C Schopflin, G Stehle, G Munzert, H Dohner and M Schmid (2005) “CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q”, Haematologica. Pavia, Italy, 90(4), pp. 489-493. doi: 10.3324/%x.